Recently, the GIP/GLP-1R co-agonist tirzepatide has gone through several randomized controlled trials and was approved by the FDA for T2DM and obesity in 2022 and 2023, respectively
The first medication approved by the US Food and Drug Administration (FDA) for weight loss was desoxyephedrine (methamphetamine) in 1947
It is hard to put into words just how excited and honoured we are to partner with the incredible team at Lemme
Zahlreiche leckere Geschmacksrichtungen von Ananas bis Zitrone entweder als Sirup Drop fr Deinen fruchtig-frischen Durstlscher oder als Geschmacks-Kick fr Sspeisen und low carb Zwischenmahlzeiten, zum Beispiel zum Verfeinern von Joghurt, Quark oder Msli
Among these, L-Glutathione stands tall as a vital molecule, often referred to as the body's 'master antioxidant.' Produced naturally within our cells, L-Glutathione is a tripeptide, meaning it's comprised of three amino acids: cysteine, glutamic acid, and glycine
Dual agonists typically target GLP-1R, GIP (glucose-dependent insulinotropic polypeptide) or IGF (insulin-like growth factor) receptors, while triple agonists target GLP-1R, GIPR, and the glucagon receptor (GCGR)
